Daily Pivots: (S1) 0.9179; (P) 0.9202; (R1) 0.9235; More…. USD/CHF’s break of 0.9200 resistance suggests that fall from 0.9372 has completed with three waves down to 0.9101. Intraday bias is back on the upside for Read more…
Daily Pivots: (S1) 1.3498; (P) 1.3528; (R1) 1.3567; More… Intraday bias in GBP/USD remains neutral and outlook is unchanged. Further rally is still expected as long as 1.3430 support holds. We’re seeing corrective fall from Read more…
Lots of noise, but little substance probably describes the last 24 hours in global markets. US equities moved sideways overnight, the US Dollar was steady versus major currencies, US yields edged a little higher, while Read more…
STMicroelectronics Announces Fourth Quarter 2021 Preliminary Revenues and Timing for its Fourth Quarter and Full Year 2021 Earnings Release and Conference Call Preliminary Q421 net revenues of $3.56 billion, above the outlook range Q4&FY21 earnings Read more…
Regulatory News: argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its strategic priorities for 2022 and highlighted recent achievements from Read more…
YOKOHAMA, Japan, Jan. 7, 2022 /PRNewswire/ — Since 2018, Cookpad Inc. has been conducting a global survey on home cooking in collaboration with Gallup, Inc. On December 2, 2021, Cookpad and Gallup released “A Global Analysis Read more…
Amsterdam , 7 January 2022 — AMG Advanced Metallurgical Group N.V. (“AMG”, EURONEXT AMSTERDAM: “AMG”) is hosting a Capital Markets Day spotlighting AMG Lithium, which will be held virtually on January 11, 2022 at 10am Read more…
Sanofi and Exscientia announced today a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilizing actual patient samples. The Read more…
Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities and personalised medicine platform Read more…
LOS ANGELES, Jan. 7, 2022 /PRNewswire/ — B. Riley Principal 150 Merger Corp. (NASDAQ: BRPMU, BRPM, BRPMW) (“BRPM”), announced today that it has filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement Read more…